NCT05252611

Brief Summary

Acceptance of chronic pain is becoming an increasingly important issue in the field of pain management. Many researchers argue that patients who accept pain better function better both physically and psychologically. In many countries, the Chronic Pain Acceptance Questionnaire - 8 (CPAQ-8) has been frequently validated and used to measure the pain acceptance of patients with chronic pain.1 However, the CPAQ-8 has not yet been introduced and validated in Turkey. In this study, we aimed to translate the English version of CPAQ-8 into Turkish, make correct cross-cultural adaptations, and validate the psychometric properties of the Turkish version of CPAQ-8 by testing it in Turkish fibromyalgia patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2020

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2020

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2021

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

February 12, 2022

Completed
11 days until next milestone

First Posted

Study publicly available on registry

February 23, 2022

Completed
Last Updated

March 14, 2022

Status Verified

February 1, 2022

Enrollment Period

Same day

First QC Date

February 12, 2022

Last Update Submit

February 25, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Fibromyalgia Impact Questionnaire

    The Fibromyalgia Impact Questionnaire was used to measure patients' symptom severity and functional status. There are 10 items in the FIQ; each item gets a score between 0-10. The first item questions the ability to perform activities of daily living with 11 questions. Other items question general well-being, ability to work, and symptoms of pain, fatigue, stiffness, anxiety, and depression. The score range is 0 to 100; higher scores indicate severe disease.

    01.01.2020-31.12.2021

Secondary Outcomes (3)

  • Hospital Anxiety and Depression Scale

    01.01.2020-31.12.2021

  • Tampa Scale of Kinesiophobia

    01.01.2020-31.12.2021

  • Brief Pain Inventory

    01.01.2020-31.12.2021

Interventions

The aim of this study is to test the validity of the Turkish version of the Chronic Pain Acceptance Questionnaire-8 (CPAQ-8).

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients who applied to our physical medicine and rehabilitation outpatient clinic, agreed to participate in the study, were over the age of 18, had at least primary school education, were diagnosed with fibromyalgia syndrome according to the 2016 American College of Rheumatology (ACR) criteria, and could speak and communicate in Turkish were included in the study.

You may qualify if:

  • Patients who applied to our physical medicine and rehabilitation outpatient clinic,
  • Agreed to participate in the study, were over the age of 18,
  • Had at least primary school education, were diagnosed with fibromyalgia syndrome according to the 2016 American College of Rheumatology (ACR) criteria,
  • Could speak and communicate in Turkish were included in the study.

You may not qualify if:

  • Those who did not agree to participate in the study,
  • \<18 years old, and could not communicate in Turkish

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ahmet Kıvanç Menekşeoğlu

Istanbul, 34015, Turkey (Türkiye)

Location

Related Publications (3)

  • Fish RA, Hogan MJ, Morrison TG, Stewart I, McGuire BE. Willing and able: a closer look at pain Willingness and Activity Engagement on the Chronic Pain Acceptance Questionnaire (CPAQ-8). J Pain. 2013 Mar;14(3):233-45. doi: 10.1016/j.jpain.2012.11.004.

    PMID: 23452647BACKGROUND
  • Fish RA, McGuire B, Hogan M, Morrison TG, Stewart I. Validation of the chronic pain acceptance questionnaire (CPAQ) in an Internet sample and development and preliminary validation of the CPAQ-8. Pain. 2010 Jun;149(3):435-443. doi: 10.1016/j.pain.2009.12.016. Epub 2010 Feb 25.

  • Kleinebrecht J, Degenhardt KH, Franz J, Schneider G. Variability of limb malformations induced by 5-fluoro-2'-deoxycytidine in mice. Teratology. 1972 Jun;5(3):295-301. doi: 10.1002/tera.1420050304. No abstract available.

MeSH Terms

Conditions

FibromyalgiaChronic Pain

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesRheumatic DiseasesNeuromuscular DiseasesNervous System DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Ahmet K Menekşeoğlu

    Kanuni Sultan Süleyman Research and Training Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 12, 2022

First Posted

February 23, 2022

Study Start

January 1, 2020

Primary Completion

January 1, 2020

Study Completion

December 31, 2021

Last Updated

March 14, 2022

Record last verified: 2022-02

Data Sharing

IPD Sharing
Will not share

Locations